I watched this webinar and thought it was interesting about the biopsy decision after a negative or clear MRI.
“In this ASPI webinar, Dr. Mark Emberton (University College London) explains how high-quality prostate MRI (and, increasingly, PSMA PET) is changing the traditional “high PSA → biopsy” pathway. For many men, these tools can help reduce unnecessary biopsies while still identifying clinically significant cancers.”